Shanghai, China

Qimei Wu

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Shanghai Synergy Pharmaceutical Sciences Co., Ltd., Shanghai Synergy Pharmaceutical Sciences, Ltd., Zhejiang Huahai Pharmaceutical Co., Ltd.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qimei Wu. Retrieved from https://idiyas.com/inventor/qimei-wu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 18.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Qimei Wu: Innovator in Amide Compounds for Medical Applications

Introduction

Qimei Wu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on amide compounds. His research focuses on the development of small molecule amide compounds that have potential applications in treating various diseases.

Latest Patents

Qimei Wu holds a patent for "Amide compounds, preparation method therefor, and use thereof in the medical field." This patent describes a method for preparing amide compounds that act as inhibitors of enhancer of Zeste homolog 2 (EZH2). These compounds can be utilized in the prevention and treatment of diseases mediated by EZH2, including tumors, myeloproliferative diseases, and autoimmune diseases. He has 1 patent to his name.

Career Highlights

Throughout his career, Qimei Wu has worked with prominent pharmaceutical companies, including Shanghai Synergy Pharmaceutical Sciences Co., Ltd. and Zhejiang Huahai Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative medical solutions.

Collaborations

Qimei Wu has collaborated with talented professionals in his field, including Xin Xu and Jia Chen. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Qimei Wu's work in the field of amide compounds represents a significant advancement in medical research. His innovative approach to developing compounds that target EZH2 has the potential to lead to new treatments for serious diseases. His contributions to the pharmaceutical industry are noteworthy and continue to inspire future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…